VKTX · Forms 3, 4, 5
Insider trades at Viking Therapeutics, Inc.
3 insiders sold $6.3M of Viking Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Viking Therapeutics, Inc. (VKTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dorothy Elizabeth Kelly-Gemmell | Director | Became an insider (Form 3) | Form 3 | ||||
| Dorothy Elizabeth Kelly-Gemmell | Director | Award | 6,333 | Form 4 | |||
| Brian Lian | President & CEO | Sell | 148,517 | $33.32 | $4.9M | Form 4 | |
| Greg Zante | Chief Financial Officer | Sell | 21,217 | $33.47 | $710K | Form 4 | |
| Marianna Mancini | Chief Operating Officer | Sell | 18,217 | $33.47 | $610K | Form 4 | |
| Brian Lian | President & CEO | Award | 221,667 | Form 4 | |||
| Greg Zante | Chief Financial Officer | Award | 31,667 | Form 4 | |||
| Marianna Mancini | Chief Operating Officer | Award | 31,667 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.